[{"NetIncomeLoss_1_Q2_USD":-15685000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":23287.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":23854.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":9000000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RepaymentsOfLongTermCapitalLeaseObligations_2_Q2_USD":24000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":9615000.0,"InterestPaidNet_2_Q2_USD":1000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":81000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":18200000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-56630000.0,"Depreciation_1_Q2_USD":600000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5149000.0,"Depreciation_2_Q2_USD":1092000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":583000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":239000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2424000.0,"AssetsCurrent_0_Q2_USD":134784000.0,"TreasuryStockShares_0_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3038672.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":3038672.0,"CapitalLeaseObligationsCurrent_0_Q2_USD":43000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2354000.0,"CommonStockSharesIssued_0_Q2_shares":27452872.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":56020000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":530000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":10213000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"Dividends_19_Q2_USD":0.0,"UnbilledReceivablesCurrent_0_Q2_USD":755000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":27257000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":12775000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":20620000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-1669000.0,"CommonStockValue_0_Q2_USD":27000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":2572000.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":64368000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":64960000.0,"ImpairmentOfInvestments_2_Q2_USD":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":16800000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q2_USD":0.0,"OtherAssetsCurrent_0_Q2_USD":208000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-34137000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-15685000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-34056000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-15551000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1436000.0,"OtherAssetsNoncurrent_0_Q2_USD":76000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":75718000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":306961000.0,"Liabilities_0_Q2_USD":22731000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":81000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":134000.0,"Assets_0_Q2_USD":144862000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":81000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":134000.0,"ShareBasedCompensation_1_Q2_USD":2204000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":1620000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":2750000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":2000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-184938000.0,"MarketableSecurities_0_Q2_USD":56020000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-20995000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":755000.0,"CommonStockSharesOutstanding_0_Q2_shares":27223796.0,"RestrictedCashNoncurrent_0_Q2_USD":1092000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":72653000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4895000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":81000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2204000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-29325000.0,"LiabilitiesCurrent_0_Q2_USD":13943000.0,"AccountsPayableCurrent_0_Q2_USD":3571000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2291000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":75718000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":17000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":76810000.0,"InterestReceivable_0_Q2_USD":205000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":54000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8910000.0,"NetIncomeLoss_2_Q2_USD":-34137000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":86000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1158000.0,"LeaseIncentivePayableCurrent_0_Q2_USD":469000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":777000.0,"ShareBasedCompensation_2_Q2_USD":3897000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":809000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2497000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1079000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"OperatingIncomeLoss_2_Q2_USD":-34720000.0,"OperatingIncomeLoss_1_Q2_USD":-15924000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4464000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":144862000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1624000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":13805000.0,"OperatingExpenses_2_Q2_USD":37470000.0,"OperatingExpenses_1_Q2_USD":17924000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":9000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.47,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.66,"ProfitLoss_2_Q2_USD":-34137000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":15000.0,"OtherLiabilitiesCurrent_0_Q2_USD":78000.0,"StockholdersEquity_0_Q2_USD":122131000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":3867000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":55939000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":426000.0,"Ticker":"FULC","CIK":"1680581","name":"FULCRUM THERAPEUTICS, INC.","OfficialName":"Fulcrum Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"518124504.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200811"}]